Gatto, A., Liu, K., Milan, N., & Wong, S
This means it takes five days for just half of the dose to leave your body
This means that at 0.25 mg weekly, the steady-state blood level of tirzepatide is approximately one-tenth of what it would be at 2.5 mg weekly
Gradually increasing the dose according to our recommendations can help minimize these issues
Europe: The European Medicines Agency oversees the approval of incretin mimetics, with drugs like Exenatide and Semaglutide approved since 2008
PubMed laboratory research record [PMID: 38607627] PubMed record related to this compound for laboratory literature review